Paper Details

  1. Home
  2. Paper Details

Effects of Silodosin, an α1A-Adrenoceptor Antagonist, and Distigmine, an Acetylcholinesterase Inhibitor, and Their Combined Effects on Impaired Voiding Function in Zucker Diabetic Fatty Rats.

Author: KobayashiMamoru, MaruyamaKazuyasu, TatemichiSatoshi, TsuchiokaKumi, YonekuboSaori

Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.

Overview

ZDF rats showed symptoms suggestive of detrusor underactivity, and silodosin tended to ameliorate these symptoms. Combined administration of an α1A-adrenoceptor antagonist with an acetylcholinesterase inhibitor may have additive efficacy.
Paper Details　
Original Abstract of the Article :
BACKGROUND/AIMS: To evaluate the effects of silodosin (α1A-adrenoceptor antagonist) and distigmine (acetylcholinesterase inhibitor), alone or in combination, on voiding dysfunction in Zucker diabetic fatty (ZDF) rats, a type 2 diabetes model, by pressure flow study. METHODS: Male ZDF rats were anes...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元：
https://doi.org/10.1159/000398811

データ提供：米国国立医学図書館（NLM）

A Two-pronged Approach to Impaired Voiding: Silodosin and Distigmine

Impaired voiding, a common problem affecting many individuals, can significantly impact quality of life. This study investigates the potential of [silodosin], an [α1A-adrenoceptor antagonist], and [distigmine], an [acetylcholinesterase inhibitor], in addressing voiding dysfunction in [Zucker diabetic fatty (ZDF) rats], a model of type 2 diabetes. The researchers explored the effects of these drugs alone and in combination, seeking to identify the most effective approach for treating impaired voiding.

Unveiling the Mechanisms of Impaired Voiding

The study found that [ZDF rats] exhibited [detrusor underactivity-like symptoms], suggesting that [α1A-adrenoceptor antagonists] may have a role in treating this condition. Both [silodosin] and [distigmine] showed improvement in impaired voiding, but the combination of both drugs was more effective than either drug alone. This suggests that targeting multiple mechanisms simultaneously may be a more effective approach to addressing this complex problem.

The Promise of Combined Therapies

This research highlights the potential of [combined therapies] in [treating impaired voiding]. It's like finding a hidden oasis that combines the refreshing coolness of a spring with the shade of a palm tree. While further research is needed to confirm these findings in humans, this study offers a promising direction for the development of new treatments for this debilitating condition.

Dr. Camel's Conclusion

Finding solutions for impaired voiding is like searching for a hidden oasis in the desert – a persistent quest for a source of relief and comfort. This research suggests that combined therapies could offer a more effective approach to addressing this complex issue, reminding us that the search for innovative treatments is an ongoing journey.

Date :
  1. Date Completed 2016-03-30
  2. Date Revised 2022-04-10
Further Info :

Pubmed ID

26023044

DOI: Digital Object Identifier

10.1159/000398811

Related Literature

Article Analysis
・Effects of silodosin
SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.